Get the Stockscreener App
92.18
0.29%
0.27
After Hours:
92.01
-0.17
-0.18%
Amedisys Inc stock is traded at $92.18, with a volume of 412.34K.
It is up +0.29% in the last 24 hours and up +9.13% over the past month.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
See More
Previous Close:
$91.91
Open:
$92
24h Volume:
412.34K
Relative Volume:
0.76
Market Cap:
$3.02B
Revenue:
$2.32B
Net Income/Loss:
$82.93M
P/E Ratio:
36.58
EPS:
2.52
Net Cash Flow:
$203.54M
1W Performance:
+0.22%
1M Performance:
+9.13%
6M Performance:
-5.55%
1Y Performance:
-2.73%
1-Day Range:
$92.00
$92.64
1-Week Range:
$91.56
$92.64
52-Week Range:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Name
Amedisys Inc
Sector
Industry
Phone
(225) 292-2031
Address
3854 AMERICAN WAY, BATON ROUGE, LA
Compare AMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
92.18 | 3.02B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
318.47 | 80.67B | 69.62B | 5.93B | 5.88B | 22.27 |
|
DVA
Davita Inc
|
169.97 | 14.91B | 12.67B | 827.68M | 1.42B | 9.27 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.09 | 13.55B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
134.43 | 13.13B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
188.78 | 12.45B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-07-23 | Downgrade | Truist | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Mar-13-23 | Initiated | Barclays | Equal Weight |
| Oct-27-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-02-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Initiated | Stifel | Hold |
| Jun-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-01-22 | Upgrade | UBS | Sell → Neutral |
| Feb-25-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-25-22 | Reiterated | Credit Suisse | Outperform |
| Feb-25-22 | Reiterated | Oppenheimer | Outperform |
| Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-25-22 | Reiterated | Raymond James | Outperform |
| Feb-25-22 | Reiterated | Truist | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-10-21 | Reiterated | The Benchmark Company | Buy |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-20-20 | Resumed | Barclays | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Buy |
| Jun-18-20 | Upgrade | The Benchmark Company | Hold → Buy |
| May-07-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-09-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-17-20 | Initiated | Credit Suisse | Outperform |
| Nov-01-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-22-19 | Resumed | Stephens | Equal-Weight |
| Sep-17-19 | Initiated | Deutsche Bank | Buy |
| May-02-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-14-18 | Initiated | Barclays | Equal Weight |
| Nov-16-18 | Initiated | UBS | Neutral |
| Oct-30-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-03-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-19-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-09-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-08-17 | Reiterated | Mizuho | Buy |
| Nov-02-17 | Upgrade | The Benchmark Company | Hold → Buy |
| Aug-21-17 | Initiated | BofA/Merrill | Neutral |
View All
Amedisys Inc Stock (AMED) Latest News
Oak Thistle LLC Purchases 3,440 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Home Care Service Market Set to Witness Significant Growth, 2025-2032 | Amedisys Inc, LHC Group, Brookdale - EIN News
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
UnitedHealth, Amedisys ask judge to toss antitrust lawsuit - Modern Healthcare
Amedisys halts deal to divest more than 100 home health centers - The Advocate
Amedisys cancels sale of home health centers to VCG Luna - Investing.com India
Amedisys cancels sale of home health centers to VCG Luna By Investing.com - Investing.com South Africa
UnitedHealth Wants $3.3B Amedisys Deal Challenge Tossed - Law360
UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring - The Wall Street Journal
UnitedHealth Says US Hiding Key Info in Suit Over Amedisys Deal - Bloomberg Law
Amedisys Inc filed SEC Form 8-K: Other Events - Quantisnow
VitalCaring Deal Reportedly Suspended As UnitedHealth, Amedisys Seek Path Forward - Home Health Care News
[UPDATED] Amedisys Halts Sale of Home Health, Hospice Locations to VitalCaring - Hospice News
UnitedHealth, Amedisys delay close date of $3.3B merger - Healthcare Dive
DOJ Wants Oct. Amedisys Trial, UnitedHealth Wants Aug. - Law360
Hospital-At-Home Market Top PlayersAmedisys, Aurora - openPR
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Principal Financial Group Inc. Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED) - Defense World
UnitedHealth, Amedisys Stocks In Focus As $3.3B Merger Deadline Extended Amid DOJ Wrangling: Retail Guarded - MSN
President and CEO Ashworth Richard M covered exercise/tax liability with 11,079 shares, decreasing direct ownership by 10% to 101,609 units (SEC Form 4) - Quantisnow
Chief Legal Officer Griffin Jennifer G covered exercise/tax liability with 3,507 shares, decreasing direct ownership by 20% to 14,000 units (SEC Form 4) - Quantisnow
Amedisys stock holds as merger deal with UnitedHealth extended By Investing.com - Investing.com Nigeria
Amedisys shares retain Outperform rating with analyst highlighting UNH acquisition alignment - Investing.com Nigeria
Death Care Market Projected To Witness Substantial Growth, 2024-2031:Carriage Services, Inc., Amedisys, Inc. - EIN News
Death Care Market Projected To Witness Substantial Growth, 2024-2031:Carriage Services, Inc., Amedisys, Inc. Dignity PLC - WICZ
UnitedHealth, Amedisys extend deadline for M&A deal - The Business Journals
Short Interest in Amedisys, Inc. (NASDAQ:AMED) Decreases By 14.7% - MarketBeat
UnitedHealth, Amedisys waive right to terminate merger pact - Yahoo Finance
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger - MSN
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal - MSN
UnitedHealth, Amedisys Move Ahead With New Waiver To Complete $3.3 Billion Deal - Home Health Care News
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More - MSN
Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal - MSN
Stocks fall, Amedisys deal extension, Netflix-NFL record: Market Minute - Yahoo Finance
Amedisys (NASDAQ:AMED) Shares Gap UpWhat's Next? - MarketBeat
Amedisys and UnitedHealth Extend Merger DeadlineWhat's Going On? - Benzinga
Amedisys Sees Unusually Large Options Volume (NASDAQ:AMED) - MarketBeat
UnitedHealth, Amedisys extend window to finish $3.3B deal - Modern Healthcare
UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny - Proactive Investors USA
UnitedHealth, Amedisys Extend Window to Complete Deal - Yahoo Finance
Amedisys and UnitedHealth amend merger agreement terms - Investing.com India
Amedisys and UnitedHealth amend merger agreement terms By Investing.com - Investing.com South Africa
UnitedHealth: deadline extended for merger with Amedisys - Marketscreener.com
UnitedHealth (UNH), Amedisys (AMED) Extend Window to Finish $3.3 Billion Deal - Bloomberg
Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal - Yahoo Finance
UnitedHealth, Amedisys extend merger deadline amid DOJ scrutiny By Investing.com - Investing.com Canada
UnitedHealth, Amedisys Extend $3.3B Deal Deadline - Newsmax
Amedisys Inc Stock (AMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):